Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesResults of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma
Cancer, 09/10/09
Glaspy J et al. – Despite the occurrence of treatment–related serious adverse events, ~80% of patients continued treatment. The higher dose of lenalidomide did not improve response rate, time to progression, or OS of patients with relapsed/refractory stage IV melanoma. A parallel placebo–controlled study has been conducted to further assess the efficacy of lenalidomide in stage IV melanoma patients.
Related Articles
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09
Relevance Score: 69%
Analysis of Globule Types in Malignant Melanoma
Archives of Dermatology, 11/17/09
Relevance Score: 68%
Ground-glass nodules found in two patients with malignant melanomas: different growth rate and different histology
Clinical Imaging, 11/17/09
Relevance Score: 68%
Unusual variants of malignant melanoma
Clinics in Dermatology, 11/06/09
Relevance Score: 67%
Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma
Modern Pathology, 10/23/09
Relevance Score: 67%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Persistence of Betapapillomavirus Infections as a Risk Factor for Actinic Keratoses, Precursor to Cutaneous Squamous Cell Carcinoma
Cancer Research, 12/08/09
Developing the readiness to alter sun-protective behaviour questionnaire (RASP-B)
Cancer Epidemiology, 12/08/09
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
International Journal of Cancer, 12/08/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09
Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Haematologica, 12/08/09
New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09
Sponsor
Article Search
Sponsor
Sponsor